There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.
The answer is to really make the Exchanges the focal point of liquidity for healthcare insurance.

Teva Ready for Higher Prices Real Money Pro($)

The money flow has turned positive.

HCA Holdings Is Red Hot Real Money Pro($)

This name is setting up well for a run to new highs.
The sector decisively has pushed through upward resistance levels in place for many months.

Biogen Ready for a Big Bounce Real Money Pro($)

The chart shows this stock has bottomed.
Selling in-the-money puts offers upside while waiting for fundamentals to turn.
Indicators are pointing to a decline back to the 2016 low.
It is hard to tell if $76 will be broken, but honestly, it does not look like strong support.
I think caution is warranted if we rally again like this.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.